Seer appoints new finance chief: what it means for Seer stock
Published on 10/16/2026 at 03:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLeadership transition and next report
- David Horn resigned on September 14, 2026, starting Seer's finance transition.
- Charles Endweiss assumed key finance roles effective October 1, 2026.
- Seer expects its next earnings announcement on November 5, 2026.
Seer (ISIN US81578P1066) disclosed a finance leadership transition on September 21, 2026, with Charles Endweiss taking key reporting roles effective October 1. According to Seer, David Horn departed as president, chief financial officer and treasurer to pursue another opportunity.
What changes on October 1?
The board appointed Omid Farokhzad as president alongside his existing roles as chief executive officer and chair. Endweiss became treasurer, principal financial officer and principal accounting officer, bringing 49 years of age and finance experience at Seer since January 2021, according to the company's September 21 release.
Three finance milestones in 2026
On September 14, 2026, David Horn resigned as president, chief financial officer and treasurer, according to StockTitan. On September 17, 2026, the board appointed Farokhzad as president. On October 1, 2026, Farokhzad and Endweiss began their additional roles.
Revenue remains the key test
Seer's second-quarter 2026 revenue was USD 3.10 million, down 23.00 percent from the prior-year quarter, while the net loss reached USD 16.90 million, according to Friday Furnace. Management maintained full-year 2026 revenue guidance of USD 16.00 million to USD 18.00 million, making financial reporting continuity relevant as the company works to improve its operating profile.
Next report sets the next checkpoint
Seer is scheduled to report third-quarter 2026 results on November 5, 2026, after the market close, with a conference call scheduled for 4:30 p.m. ET, according to MarketBeat. The expected report will give investors a fresh comparison with the USD 3.10 million second-quarter revenue base.
Finance leadership meets operating pressure
Seer's Proteograph platform remains the company's central business, while the 23.00 percent second-quarter revenue decline and USD 16.90 million net loss define the near-term reporting challenge. The October transition therefore matters most through the quality and continuity of the next financial update.
Seer stock key facts
- Company: Seer, Inc.
- ISIN: US81578P1066
- Ticker: SEER
- Primary exchange: Nasdaq Global Select Market
- Sector / Industry: Healthcare / Biotechnology
- Next earnings date: November 5, 2026
Market context: Market report S&P 500.
